The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma
Sathyen A. Prabhu(Jewish General Hospital), Sonia V. del Rincón(McGill University)
Cited by 37
Related Papers
Spatially mapping the immune landscape of melanoma using imaging mass cytometry
|Science Immunology|2022|131
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma
|Journal of Clinical Investigation|2017|76
Raw CyTOF images associated with Moldoveanu et al. 2022, Science Immunology
|Zenodo (CERN European Organization for Nuclear Research)|2022|1
Multi-platform characterization of cutaneous melanoma from patients treated with immune checkpoint inhibitors.
|Journal of Clinical Oncology|2018|0